Home

Michael J Baughman

CIK 1363092 · Exec VP, CFO & CAO · last filed 2025-12-10

Michael J Baughman is an Exec VP, CFO & CAO who has filed 31 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for EMR, was dated Dec 10, 2025. Across all open-market trades the lifetime net is −$4.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $20.3M across reported positions. 19 SEC filings were submitted jointly with BAXTER INTERNATIONAL INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.33M

Companies

2

Total Filings

31

Lifetime Open-Market Net

-$4.59M

Filer Profile

Reported Address
EMERSON ELECTRIC CO.
8000 W. FLORISSANT AVENUE
ST. LOUIS, MO 63136
Related Filers
BAXTER INTERNATIONAL INC — 19 joint filings, latest 2013-01-18
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EMR Exec VP, CFO & CAO 126,776 $154.59 $19.60M $0 13 2025-12-10
BAX Corporate Vice President 31,180 $23.49 $732.4K -$4.59M 18 2013-01-18

Recent Filings

31 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-12-10 EMR Gift (G) −4,000 $0 EDGAR
2025-11-10 EMR Tax (F) −2,049 -$271.9K EDGAR
2025-11-06 EMR Tax (F) −1,981 -$274.0K EDGAR
2025-11-05 EMR Mixed +33,380 -$2.26M EDGAR
2024-11-08 EMR Tax (F) −2,053 -$257.5K EDGAR
2024-11-06 EMR Mixed +20,625 -$668.0K EDGAR
2023-11-08 EMR Grant (A) +23,917 $0 EDGAR
2022-11-02 EMR Grant (A) +8,788 $0 EDGAR
2021-11-03 EMR Grant (A) +17,221 $0 EDGAR
2021-10-20 EMR Tax (F) −1,231 -$117.3K EDGAR
Showing 1–10 of 31
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.